학술논문

Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.
Document Type
article
Author
Butler-Laporte, GuillaumePovysil, GundulaKosmicki, JackCirulli, ElizabethDrivas, TheodoreFurini, SimoneSaad, ChadiSchmidt, AxelOlszewski, PawelKorotko, UrszulaQuinodoz, MathieuÇelik, ElifnazKundu, KousikWalter, KlaudiaJung, JunghyunStockwell, AmySloofman, LauraJordan, DanielThompson, RyanDel Valle, DianeSimons, NicoleCheng, EstherSebra, RobertSchadt, EricKim-Schulze, SeungheeGnjatic, SachaMerad, MiriamBuxbaum, JosephBeckmann, NoamCharney, AlexanderPrzychodzen, BartlomiejChang, TimothyPottinger, TessShang, NingBrand, FabianFava, FrancescaMari, FrancescaChwialkowska, KarolinaNiemira, MagdalenaPula, SzymonBaillie, JStuckey, AlexSalas, AntonioBello, XabierPardo-Seco, JacoboGómez-Carballa, AlbertoRivero-Calle, IreneMartinón-Torres, FedericoGanna, AndreaKarczewski, KonradVeerapen, KumarBourgey, MathieuBourque, GuillaumeEveleigh, RobertForgetta, VincenzoMorrison, DavidLanglais, DavidLathrop, MarkMooser, VincentNakanishi, TomokoFrithiof, RobertHultström, MichaelLipcsey, MiklosMarincevic-Zuniga, YanaraNordlund, JessicaSchiabor Barrett, KellyLee, WilliamBolze, AlexandreWhite, SimonRiffle, StephenTanudjaja, FranciscoSandoval, EfrenNeveux, IvaDabe, ShaunCasadei, NicolasMotameny, SusanneAlaamery, ManalMassadeh, SalamAljawini, NoraAlmutairi, MansourArabi, YaseenAlqahtani, SalehAl Harthi, FawzAlmutairi, AmalAlqubaishi, FatimaAlotaibi, SarahBinowayn, AlbandariAlsolm, EbtehalEl Bardisy, HadeelFawzy, MohammadCai, FangSoranzo, NicoleButterworth, AdamGeschwind, DanielArteaga, StephanieStephens, AlexisButte, ManishBoutros, PaulYamaguchi, TakafumiTao, Shu
Source
PLoS Genetics. 18(11)
Subject
Humans
Exome
Genome-Wide Association Study
COVID-19
Genetic Predisposition to Disease
Toll-Like Receptor 7
SARS-CoV-2
Language
Abstract
Host genetics is a key determinant of COVID-19 outcomes. Previously, the COVID-19 Host Genetics Initiative genome-wide association study used common variants to identify multiple loci associated with COVID-19 outcomes. However, variants with the largest impact on COVID-19 outcomes are expected to be rare in the population. Hence, studying rare variants may provide additional insights into disease susceptibility and pathogenesis, thereby informing therapeutics development. Here, we combined whole-exome and whole-genome sequencing from 21 cohorts across 12 countries and performed rare variant exome-wide burden analyses for COVID-19 outcomes. In an analysis of 5,085 severe disease cases and 571,737 controls, we observed that carrying a rare deleterious variant in the SARS-CoV-2 sensor toll-like receptor TLR7 (on chromosome X) was associated with a 5.3-fold increase in severe disease (95% CI: 2.75-10.05, p = 5.41x10-7). This association was consistent across sexes. These results further support TLR7 as a genetic determinant of severe disease and suggest that larger studies on rare variants influencing COVID-19 outcomes could provide additional insights.